PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $828,000 | -70.2% | 262,907 | -72.4% | 0.00% | -75.0% |
| Q2 2020 | $2,776,000 | -28.6% | 953,865 | -30.8% | 0.00% | -42.9% |
| Q1 2020 | $3,890,000 | -46.4% | 1,379,387 | -38.3% | 0.01% | -12.5% |
| Q4 2019 | $7,251,000 | +93.2% | 2,234,476 | +28.6% | 0.01% | +100.0% |
| Q3 2019 | $3,754,000 | -31.3% | 1,737,877 | -0.1% | 0.00% | -33.3% |
| Q2 2019 | $5,463,000 | -38.2% | 1,739,713 | -26.8% | 0.01% | -33.3% |
| Q1 2019 | $8,843,000 | +34.9% | 2,377,054 | +5.1% | 0.01% | +12.5% |
| Q4 2018 | $6,556,000 | -13.9% | 2,260,849 | -21.9% | 0.01% | +14.3% |
| Q3 2018 | $7,610,000 | -24.2% | 2,893,649 | -32.6% | 0.01% | -30.0% |
| Q2 2018 | $10,042,000 | -29.2% | 4,291,443 | -11.1% | 0.01% | -33.3% |
| Q1 2018 | $14,192,000 | -3.3% | 4,827,105 | -9.9% | 0.02% | 0.0% |
| Q4 2017 | $14,682,000 | -9.9% | 5,358,325 | +11.5% | 0.02% | -21.1% |
| Q3 2017 | $16,287,000 | +51.2% | 4,804,305 | +10.2% | 0.02% | +35.7% |
| Q2 2017 | $10,772,000 | +4.4% | 4,360,986 | -4.1% | 0.01% | 0.0% |
| Q1 2017 | $10,321,000 | +30.7% | 4,546,501 | +22.0% | 0.01% | +27.3% |
| Q4 2016 | $7,899,000 | -14.3% | 3,726,020 | +35.5% | 0.01% | -21.4% |
| Q3 2016 | $9,215,000 | +30.5% | 2,750,787 | +22.3% | 0.01% | +16.7% |
| Q2 2016 | $7,062,000 | +3.5% | 2,248,913 | +9.8% | 0.01% | 0.0% |
| Q1 2016 | $6,822,000 | -6.1% | 2,048,869 | -0.2% | 0.01% | -7.7% |
| Q4 2015 | $7,266,000 | +356.1% | 2,052,587 | +548.1% | 0.01% | +333.3% |
| Q3 2015 | $1,593,000 | +83.3% | 316,708 | +134.3% | 0.00% | +50.0% |
| Q2 2015 | $869,000 | +362.2% | 135,153 | +406.9% | 0.00% | – |
| Q1 2015 | $188,000 | -51.5% | 26,664 | -47.0% | 0.00% | -100.0% |
| Q4 2014 | $388,000 | -77.2% | 50,334 | -77.9% | 0.00% | -80.0% |
| Q3 2014 | $1,701,000 | -87.8% | 227,709 | -84.2% | 0.01% | -86.8% |
| Q2 2014 | $13,982,000 | +9.2% | 1,444,460 | -6.3% | 0.04% | -2.6% |
| Q1 2014 | $12,805,000 | +367.2% | 1,540,860 | +374.4% | 0.04% | +387.5% |
| Q4 2013 | $2,741,000 | -49.3% | 324,809 | -52.1% | 0.01% | -57.9% |
| Q3 2013 | $5,401,000 | -76.5% | 677,670 | -77.2% | 0.02% | -76.8% |
| Q2 2013 | $22,972,000 | -10.7% | 2,975,678 | -18.4% | 0.08% | -25.5% |
| Q4 2012 | $25,721,000 | – | 3,648,370 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KESTREL INVESTMENT MANAGEMENT CORP | 1,585,500 | $3,710,000 | 1.36% |
| SMH CAPITAL ADVISORS INC | 83,369 | $195,000 | 0.32% |
| West Family Investments, Inc. | 338,141 | $791,000 | 0.20% |
| Matarin Capital Management, LLC | 927,289 | $2,169,856,000 | 0.16% |
| ROCKY MOUNTAIN ADVISERS, LLC | 14,300 | $33,000 | 0.12% |
| Alambic Investment Management, L.P. | 163,200 | $382,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,760,376 | $4,119,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 5,677,647 | $13,286,000 | 0.08% |
| Zebra Capital Management LLC | 67,892 | $159,000 | 0.07% |
| Fortis Advisors, LLC | 45,602 | $107,000 | 0.06% |